Latest Women's Health News

16May
2023

Marijuana Can Affect Fetal Development, Even If Used Early in Pregnancy

Marijuana Can Affect Fetal Development, Even If Used Early in PregnancyTUESDAY, May 16, 2023 (HealthDay News) -- As recreational marijuana use rises, some dispensaries are recommending it as a remedy for morning sickness, but new research warns that using it during pregnancy may significantly affect fetal growth.While fetal exposure to cannabis in early pregnancy can reduce birth weight, those effects can become more severe if use continues throughout the pregnancy, according to researchers at Central Michigan University in Mount Pleasant, Mich.“We show that even when marijuana use occurred only in the first trimester of pregnancy, birth weight was significantly reduced, by more than 150 grams (5.3 ounces) on average,” said senior study author Dr. Beth Bailey, a professor and director of population health research. “If that use continued into the...

Is That Hand-Me-Down Crib or Stroller Safe? Most Parents...

15 May 2023
Is That Hand-Me-Down Crib or Stroller Safe? Most Parents Unsure, Survey FindsMONDAY, May 15, 2023 (HealthDay News) – Baby equipment is costly, so many parents buy it used, but they’re not always sure whether it’s still safe, a nationwide poll reveals.About half of the 932 parents surveyed in February said they had used pre-owned equipment for their baby, most often cribs and high chairs, according to a University of Michigan Health C.S. Mott Children’s Hospital poll released May 15.Yet, 2 in 3 said it was hard to tell if the equipment was safe.“Used child essentials are often more cost-effective, environmentally friendly and convenient,” said poll co-director Sarah Clark. “However, many parents in our poll weren’t completely confident they could identify safety concerns, such as unsafe wear and tear, recalls or hygiene issues.”About half said...

Severe Obesity Could Mean Faster Decline of Immunity...

12 May 2023
Severe Obesity Could Mean Faster Decline of Immunity From COVID ShotFRIDAY, May 12, 2023 (HealthDay News) -- Severely obese people may need more frequent COVID-19 booster shots to keep their immunity going, new research suggests. Protection from the shots declines more rapidly in those who are severely obese compared to those at a normal weight, according to scientists at the Universities of Cambridge and Edinburgh in the United Kingdom. "Because of the high prevalence of obesity across the globe, this poses a major challenge for health services,” study co-author Sadaf Farooqi said in a Cambridge news release. She is from the Wellcome-MRC Institute of Metabolic Science at Cambridge. Past research has shown that COVID vaccination has been highly effective at reducing symptoms, hospitalization and death, including for people with obesity. Yet antibody...

ER Visits by Teens in Mental Health Crisis Have...

11 May 2023
ER Visits by Teens in Mental Health Crisis Have Declined: CDCTHURSDAY, May 11, 2023 (HealthDay News) -- There’s a glimmer of good news when it comes to the mental health of America’s adolescents: Visits to U.S. emergency departments for psychiatric troubles declined among kids aged 12 to 17 by the fall of 2022, compared to a year prior.Overall, mean weekly adolescent emergency department (ED) visits for mental health conditions fell by 11% last fall, compared to higher levels in the fall of 2021, when the pandemic was still keeping many kids out of school and in lockdown at home. According to data compiled by the U.S. Centers for Disease Control and Prevention, similar year-on-year declines were also seen for adolescent ED visits linked to thoughts of suicide (down 12%) and drug overdoses (down 10%).Why the improvement in teens’ mental...

Vaccine Slows Return of Pancreatic Cancer in Early Trial

11 May 2023
Vaccine Slows Return of Pancreatic Cancer in Early TrialTHURSDAY, May 11, 2023 (HealthDay News) – A gene-targeted personalized vaccine may delay the return of pancreatic cancer according to a small, but promising, trial.The mRNA vaccine, which was tailored to the genetic makeup of each patient's tumor, worked in half of those who received it during 18 months of follow-up, researchers reported May 10 in the journal Nature.Scientists at BioNTech (known for developing a COVID vaccine with Pfizer during the pandemic) and Genentech created the novel vaccine. Experts reacted to the news with cautious hope.“It’s relatively early days,” Dr. Patrick Ott, of the Dana-Farber Cancer Institute in Boston, told the New York Times.“This is the first demonstrable success — and I will call it a success, despite the preliminary nature of the study...
RSS
First45679111213Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.